By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Integral Molecular, Inc. 

3701 Market Street, Suite 340

Philadelphia  Pennsylvania  19104  U.S.A.
Phone: 215-966-6018 Fax:



Start Up

Company News
Integral Molecular, Inc. Awarded $3.5M Contract From NIH To Study Ebola And Hepatitis C Virus Antibody Response 11/14/2014 10:46:31 AM
Integral Molecular, Inc. Announces Patent Allowance For Dengue Research Technology 7/18/2014 10:44:47 AM
Integral Molecular, Inc. Announces Patent Protecting The Use Of Lipoparticles For Antibody Discovery 3/31/2014 8:33:09 AM
Integral Molecular, Inc. Identifies Potent Antibody Antagonists Against Ion Channel Pain Target P2X3 12/12/2013 9:06:53 AM
Integral Molecular, Inc. Announces Issuance of Third Patent Family, Extending Patent Landscape for Key Lipoparticle Technology 11/7/2013 7:34:00 AM
Integral Molecular, Inc. and Crystal Bioscience Announce Research Collaboration to Develop Novel GPCR and Ion Channel Antibodies 11/16/2012 9:01:13 AM
Integral Molecular, Inc. Announces Patent Allowance for its Membrane Protein Lipoparticle Technology 5/4/2012 10:07:02 AM
Integral Molecular, Inc. Announces Lipoparticle Distribution in Japan by Funakoshi Co. 4/25/2012 10:18:40 AM
Integral Molecular, Inc. to Expand its Headquarters at the Science Center in Philadelphia 11/15/2010 11:08:51 AM
Integral Molecular, Inc. Awarded $9.1 Million Contract from National Institute of Allergy And Infectious Diseases (NIAID) to Map Epitopes on Viral Pathogens Using Shotgun Mutagenesis Mapping Technology 11/3/2009 8:41:45 AM